Precision Genetics has developed a test that can detect the presence of both COVID-19 and the Flu (Influenza A and B) from a single sample. The combination makes diagnosing the cause of a patient’s symptoms clear for patients and providers. “By utilizing our high-complexity laboratory and testing methods, we can quickly and accurately distinguish between these viral infections,” said Nate Wilbourne, founder and CEO of Precision Genetics.
